News and Events

  • Emerging Biomarkers in Alcohol Associated Liver Disease

    Posted: February 7, 2023

    It’s Not Just Support. It’s Solutions.   Non-Invasive Biomarkers for Alcohol Associated Liver Disease Studies Biomarkers of cell death and regeneration, inflammation, and immune response become useful tools as new potential Alcohol Associated Liver Disease (ALD) and Alcohol Associated Hepatitis (AH) treatment options are investigated. Serum biomarkers can provide valuable insights into: Disease severity and…

    Read More

  • You name it, Ceveron® s100 can do it

    Posted: February 3, 2023

    It’s Not Just Support. It’s Solutions.    Discover the Ceveron® s100 The first fully-automated coagulation analyzer to combine classic technologies with high-powered LEDs for fluorescent and quenching resonance transfer assays. Perform clotting, chromogenic, and turbidometric hemostasis assays plus Thrombin Generation Testing, ADAMTS13 activity, and FXIII activity all with one instrument. Why Ceveron® s100? Automate your…

    Read More

  • Axes, Rage, and VR at DiaPharma?

    Posted: February 2, 2023

    It’s Not Just Support. It’s Solutions.    Kicking off 2023 Axes, rage, and VR at DiaPharma? At our national sales meeting, there is! DiaPharma held our national sales meeting in January – it’s a chance to see each other in person, plan the year ahead, and have some fun! DiaPharma staff tried our hands at…

    Read More

  • Because matrix matters! The path to lung disease is paved with MMPs and collagen

    Posted: December 14, 2022

    It’s Not Just Support. It’s Solutions.    DiaPharma and QuickZyme Know Matrix Matters! QuickZyme specializes in collagen assays and MMP activity assays (MMP-2, MMP-7, MMP-8, MMP-9, MMP-14). These assays were developed by scientists to fill an unmet need as an alternative to laborious methods. The assays give a more granular insight to the role that…

    Read More

  • Thank you for visiting us at The Liver Meeting®

    Posted: November 11, 2022

    It’s Not Just Support. It’s Solutions.    DIAPHARMA AND VLVbio THANK YOU! We enjoyed meeting so many of you in-person at the AASLD The Liver Meeting®, and sharing new studies using CK18/K18-M30® and CK18/K18-M65® as blood-based biomarkers in the world of NASH, acute alcohol-associated hepatitis, and DILI. DiaPharma has also added new and unique assay…

    Read More

  • What’s New at DiaPharma?

    Posted: November 9, 2022

    It’s Not Just Support. It’s Solutions.    DiaPharma in the Community DiaPharma staff supports many impactful causes. DiaPharma and our staff proudly sponsor events close to our hearts and our community. Most recently, DiaPharma sponsored Ross’s Race in the Alzheimer’s Association Walk to End Alzheimer’s®, and the Circle Tail Golf Classic for Circle Tail assistance…

    Read More

  • Overworked staff? The T-TAS® 01 platelet function analyzer can lighten the burden

    Posted: October 18, 2022

    It’s Not Just Support. It’s Solutions. T-TAS® 01 PL Assay: One test, one result, one total answer for platelet function Help address staffing and budgetary challenges with a frontline test for overall total platelet function Single assay with easy-to-interpret test result provides simple and comprehensive platelet reactivity status Consolidate testing from multiple platforms, for better…

    Read More

  • Go further than FEV1 and FVC – Mechanistic Biomarkers for Lung Disease

    Posted: October 11, 2022

    It’s Not Just Support. It’s Solutions. A Case for Letting Endotype Lead the Way in Drug Development…   Neutrophilic      VS      Eosinophilic The molecular mechanisms that drive chronic lung disease are heterogenetic. To evolve past a “one drug fits all approach”, toward a more individualized and precision approach, pharmaceutical companies are focusing…

    Read More

  • Factor XIII Assays to Fit Your Needs

    Posted: September 30, 2022

    t’s Not Just Support. It’s Solutions. Factor XIII Activity Assays – The Right Fit for your Needs Manual and automated solutions for measuring FXIII Activity Technofluor® Factor XIII Fully automated on the Ceveron s100 for the determination of FXIII activity levels. Minimal hands-on time Data in under 30 minutes Single calibration per lot No need…

    Read More

  • Endotyping for Clinical Trial Success with COPD, bronchiectasis, asthma

    Posted: September 29, 2022

    It’s Not Just Support. It’s Solutions. Endpoints for clinical trials in lung disease could be better… FEV1 and FVC are relatively blunt tools for getting a complete picture of a disease state – they do not provide information on the pulmonary microenvironment. Inflammation is a hallmark of chronic lung diseases and an important piece of…

    Read More

  • Measure fibrosis in a more meaningful way using TOTAL collagen assays

    Posted: September 28, 2022

    It’s Not Just Support. It’s Solutions. Let DiaPharma introduce you to a new partner in fibrosis research, QuickZyme Biosciences DiaPharma is excited to announce that we now offer QuickZyme products. QuickZyme knows, “Matrix Matters”. Collagens are a main component of the extracellular matrix and are the most abundant proteins in the body. Collagens play important…

    Read More

  • Tools for Sickle Cell Disease Research

    Posted: September 22, 2022

    It’s Not Just Support. It’s Solutions. Tools for Sickle Cell Disease Research September is National Sickle Cell Awareness Month. From Anti-Hemoglobin S antibodies, coagulation kits, and biomarker assays, to exciting new instrumentation for clotting analysis, DiaPharma has what matters covered for impactful Sickle Cell research. Research projects like gene therapy require many decisions, including investigating…

    Read More

  • Time to include Human TSP2 in your next NASH study?

    Posted: September 14, 2022

    It’s Not Just Support. It’s Solutions.   Time to include Thrombospondin-2 in your next NASH study… Thrombospondin-2 has been identified by transcriptomics as an emerging NASH biomarker. Protein analysis shows that it has promise for use in studying NAFLD, NASH, metabolic disease, and diabetes. This Human TSP2 ELISA kit, from ImmunoDiagnostics, is proven reliable for…

    Read More

  • What’s New at DiaPharma?

    Posted: August 15, 2022

    It’s Not Just Support. It’s Solutions. Meet Genesis Cautivar West Territory Manager Genesis Cautivar joined DiaPharma in July 2022. He is a native of Vancouver, British Columbia, Canada and currently resides in the Dallas-Fort Worth, Texas Metroplex. He received his B.S. in Medical Technology from Walla Walla University (WA). He has many years of experience…

    Read More

  • Exploratory Biomarkers for Acute and Chronic Kidney Injury Studies

    Posted: June 28, 2022

    It’s Not Just Support. It’s Solutions. Spotlight on Acute and Chronic Kidney Injury Enhanced assays with improved sensitivity and specificity to assist in kidney disease studies L-FABP ● NGAL ● Osteopontin ● alpha-GST ● Cystatin C ● RBP4 ● Anti-EHEC There are large gaps in the information that standard kidney markers, like serum creatinine, can…

    Read More

  • News from the front lines at SOT 2022: Checkpoint Inhibitor Liver Toxicity

    Posted: June 7, 2022

    It’s Not Just Support. It’s Solutions.   Spotlight on Liver Toxicity: Immune-mediated Liver Injury Caused by Checkpoint Inhibitors (ILICI) One thing that jumped out at the Society of Toxicology (SOT) meeting this past March was a new phase of liver toxicology research focused on therapies that have a direct effect on immune function, specifically, hepatotoxicity…

    Read More

  • Measure True Beta Cell Dysfunction with TECO Intact Proinsulin

    Posted: June 6, 2022

    It’s Not Just Support. It’s Solutions. When it comes to measuring pancreatic Beta cell function, go with the Pro! TECO® Intact Proinsulin ELISA Save time and guess work by selectively measuring only intact proinsulin. Proinsulin is synthesized in pancreatic β-cells and secreted as insulin. Insulin resistance (IR) or hyperglycemia causes increased secretion and finally secretion…

    Read More

  • T-TAS®01 – The Leading Edge in Platelet Thrombus Formation Assessment

    Posted: June 1, 2022

    It’s Not Just Support. It’s Solutions. Innovative Total Platelet Function Analysis using Whole Blood Global evaluation of overall hemostatic ability using physiologic, flow conditions Exclusively from DiaPharma. Advantages of T-TAS® 01 PL Assay Ease of Interpretation A numeric cut-off easily identifies those with primary hemostasis disorders, assisting with more timely determination of appropriate treatment strategy…

    Read More

  • Respiratory Research Solutions from DiaPharma

    Posted: May 16, 2022

    It’s Not Just Support. It’s Solutions. DiaPharma is Your Exclusive Source for ProAxsis products   Reach out to DiaPharma’s Olivia Stricker, who will be at American Thoracic Society (ATS) 2022 in San Francisco, May 13 – 16. Elevate your clinical research data by measuring active proteases Targets: Drug development evaluating new protease inhibitors or anti-inflammatory…

    Read More

  • Comprehensive Solutions for Anticoagulation Research

    Posted: May 9, 2022

    It’s Not Just Support. It’s Solutions. Explore Assays from DiaPharma to Enhance Your Anticoagulation Research Whether you’re researching vitamin K antagonists, thrombin inhibitors, FXa inhibitors, or contact pathway inhibitors, you need reliable, relevant tests. DiaPharma can help you select the right assays. Thrombin Generation Testing Manual or automated options for studying potential new anticoagulants Technothrombin® TGA*…

    Read More